Lb Pharmaceuticals LBRX
NASDAQ LBRX
$40.35 -0.65 (-1.60%)
As of: Oct 21, 2026 · 2:16 PM EDT

Lb Pharmaceuticals (LBRX) Total Current Liabilities (2024 - 2026)

Updated

Lb Pharmaceuticals (LBRX) posted Total Current Liabilities of $23.56 million for Q2 2026, up 116.1% from the prior quarter.

Analysis

Lb Pharmaceuticals (LBRX) Total Current Liabilities (2024 - 2026) Analysis & Trends

At the end of FY2025, Lb Pharmaceuticals' Total Current Liabilities came in at $7.44 million, down 8.2% from FY2024.

  • In prior years, Lb Pharmaceuticals' Total Current Liabilities was $8.11 million in FY2024.
  • According to Business Quant data, Total Current Liabilities for the three prior quarters was $10.91 million (Q1 2026), $7.44 million (Q4 2025) and $6.65 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Eli Lilly 1,135.43 Bn 1,104.02 Bn 19.71 Bn 47.74 Bn
2 Johnson & Johnson 616.54 Bn 535.06 Bn 17.26 Bn 54.90 Bn
3 AbbVie 501.55 Bn 474.66 Bn 12.70 Bn 41.64 Bn
4 Merck 367.19 Bn 321.57 Bn 12.21 Bn 27.73 Bn
5 Novartis Ag 297.91 Bn 261.90 Bn 11.24 Bn 31.75 Bn
6 Astrazeneca 261.40 Bn 235.09 Bn 12.86 Bn 31.55 Bn
7 Amgen 236.18 Bn 191.58 Bn 7.24 Bn 25.50 Bn
8 Gilead Sciences 190.55 Bn 164.75 Bn 6.22 Bn 11.02 Bn
9 Pfizer 169.40 Bn 116.05 Bn 10.94 Bn 32.65 Bn
10 Lb Pharmaceuticals 1.22 Bn -87.21 Mn - 23.56 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 23.56 Mn
Mar 31, 2026 10.91 Mn
Dec 31, 2025 7.44 Mn
Sep 30, 2025 6.65 Mn
Dec 31, 2024 8.11 Mn
API Access

Lb Pharmaceuticals Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=LBRX&period=max&api_key=YOUR_API_KEY